- Healthcare Business Women
Ulrike Ciesla is a member of Meyerlustenberger Lachenal’s IP team, which ranks among the leaders in intellectual property in Switzerland. In particular, she complements the patent litigation team with her expertise in technical matters and patent law.
Ms Ciesla studied chemistry at the University of Erlangen and the University of Mainz. After her doctoral thesis in the field of inorganic solid state chemistry and catalysis at the University of Frankfurt, she was a postdoctoral researcher at the University of California, Santa Barbara, and scholar of the German Research Foundation. She is co-author of several publications, including frequently cited papers in high-impact journals such as Angewandte Chemie and Nature.
Ms Ciesla began her patent attorney career at Hoffmann Eitle, one of the largest patent law firms in Europe. In 2004 she qualified as a European patent attorney and German patent attorney and later became a partner at Hoffmann Eitle. During her almost 20 years with Hoffmann Eitle, she gained extensive experience and knowledge in patent prosecution and opposition and appeal proceedings before the German and European Patent Offices, as well as in patent litigation proceedings before courts in Germany and Switzerland.
Before joining Meyerlustenberger Lachenal as partner, Ms Ciesla was already working with the firm’s IP team on the Faslodex litigation proceedings.